Thalassaemia screening in pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 2, 2005, Pages 129-134

  Leung, Tse N ^a   Lau, Tze K ^b   Chung, Tony K H ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antenatal screening; Non invasive prenatal diagnosis; Thalassaemia; Ultrasound

Indexed keywords

BETA GLOBIN; HEMOGLOBIN;

ALPHA THALASSEMIA; ANEMIA; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE DEFORMATION; BONE MARROW TRANSPLANTATION; CHELATION THERAPY; DISEASE CLASSIFICATION; GENE DELETION; GENE MUTATION; GENOTYPE; GROWTH RETARDATION; HEMOGLOBIN DETERMINATION; HEPATOSPLENOMEGALY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; IRON CHELATION; LABORATORY DIAGNOSIS; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NON INVASIVE MEASUREMENT; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REVIEW; THALASSEMIA; THALASSEMIA MAJOR;

EID: 15944415775     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000162180.22984.a3     Document Type: Review

References (43)

1. Weatherall DJ. The thalassaemias. BMJ 1997; 314:1675-1678.
2. Davies SC, Cronin E, Gill M, et al. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess 2000; 4:1-99.
3. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987; 11:65-88.
4. Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 2004; 57:517-522.
5. Weatherall DJ, Clegg JB. Thalassemia - a global public health problem. Nat Med 1996; 2:847-849.
6. Weatherall D. 2003 William Allan Award address. The thalassemias: the role a of molecular genetics in an evolving global health problem. Am J Hum Genet 2004; 74:385-392. A good and interesting account of the history of the development of thalassaemia research.
7. Old J, Petrou M, Varnavides L, et al. Accuracy of prenatal diagnosis for haemoglobin disorders in the UK: 25 years' experience. Prenat Diagn 2000; 20:986-991.
8. Chan K, Wong MS, Chan TK, Chan V. A thalassaemia array for Southeast Asia. Br J Haematol 2004; 124:232-239. This paper reports an array for robust detection of 120 beta-thai mutants and 35 non-deletion alpha-thal mutants, allowing large-scale antenatal screening in south-east Asian countries.
9. Naja RP, Kaspar H, Shbaklo H, et al. Accurate and rapid prenatal diagnosis of the most frequent East Mediterranean beta-thalassemia mutations. Am J Hematol 2004; 75:220-224. This paper describes a rapid PCR technique for common mutations of β thalassaemia in the eastern Mediteranean region.
10. Cao A. Results of programmes for antenatal detection of thalassemia in reducing the incidence of the disorder. Blood Rev 1987; 1:169-176.
11. Tongsong T, Wanapirak C, Sirivatanapa P, et al. Prenatal control of severe thalassaemia: Chiang Mai strategy. Prenat Diagn 2000; 20:229-234.
12. Modell B, Harris R, Lane B, et al. Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. BMJ 2000; 320:337-341.
13. Lam YH, Tang MH, Lee CP, Tse HY. Prenatal ultrasonographic prediction of homozygous type 1 alpha-thalassemia at 12 to 13 weeks of gestation. Am J Obstet Gynecol 1999; 180:148-150.
14. Tongsong T, Wanapirak C, Sirichotiyakul S, Chanprapaph P. Sonographic markers of hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2004; 23:49-55. The results will be useful for counselling of at-risk couples. The sample size was large and the results are well presented.
15. Chiu RW, Lau TK, Leung TN, et al. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002; 360:998-1000.
16. Ding C, Chiu RW, Lau TK, et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004; 101:10762-10767. An exciting paper in this field. Obstetricians with no background in molecular genetics may not understand the technical part but can still appreciate the underlying theory. It is important for obstetricians to keep track of progress in this area.
17. Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 2000; 343:544-550.
18. Old JM. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev 2003; 17:43-53. An excellent review paper on screening and diagnosis of all haemoglobin disorders. The information will be useful to obstetricians, haematologists and geneticists.
19. Chan LC, Ma SK, Chan AY, et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? J Clin Pathol 2001; 54:317-320.
20. Molchanova TP, Pobedimskaya DD, Postnikov Yu V. A simplified procedure for sequencing amplified DNA containing the alpha 2- or alpha 1 -globin gene. Hemoglobin 1994; 18:251-255.
21. Lau YL, Chan LC, Chan YY, et al. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong - implications for population screening. N Engl J Med 1997; 336:1298-1301.
22. The Thalassaemia Working Party of the BCSH General Haematology Task Force. The laboratory diagnosis of haemoglobinopathies. Br J Haematol 1998; 101:783-792.
23. Chui DH, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood 2003; 101:791-800. This review highlights the potential clinical problems of haemoblobin H disease.
24. Ghosh A, Tang MH, Lam YH, et al. Ultrasound measurement of placental thickness to detect pregnancies affected by homozygous alpha-thalassaemia-1. Lancet 1994; 344:988-989.
25. O-Prasertsawat P, Suthutvoravut S, Chaturachinda K. Hydrops fetalis due to Bart hemoglobinopathy at Ramathibodi Hospital (1978-1987): a 10-year review. J Med Assoc Thai 1990; 73(Suppl 1):65-68.
26. Lam YH, Ghosh A, Tang MH, et al. Early ultrasound prediction of pregnancies affected by homozygous alpha-thalassaemia-1. Prenat Diagn 1997; 17:327-332.
27. Angastiniotis M, Modell B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci 1998; 850:251-269.
28. Ball LM, Lankester AC, Giordano PC, et al. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience. Bone Marrow Transplant 2003; 31:1081-1087.
29. Fucharoen S, Ketvichit P, Pootrakul P, et al. Clinical manifestation of beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol 2000; 22:552-557.
30. Quattrin N, Ventruto V. Hemoglobin Lepore: its significance for thalassemia and clinical manifestations. Ann N Y Acad Sci 1974; 232:65-75.
31. Tyagi S, Choudhry VP, Saxena R. Subclassification of HbS syndrome: is it necessary? Clin Lab Haematol 2003; 25:377-381.
32. Thein SL. Dominant beta thalassaemia: molecular basis and pathophysiology. Br J Haematol 1992; 80:273-277.
33. Cronin EK, Normand C, Henthorn JS, et al. Organisation and cost-effectiveness of antenatal haemoglobinopathy screening and follow up in a community-based programme. Br J Obstet Gynaecol 2000; 107:486-491.
34. Rogers M, Phelan L, Bain B. Screening criteria for beta thalassaemia trait in pregnant women. J Clin Pathol 1995; 48:1054-1056.
35. Lafferty JD, Crowther MA, Ali MA, Levine M, The evaluation of various mathematical RBC indices and their efficacy in discriminating between thalassemic and non-thalassemic microcytosis. Am J Clin Pathol 1996; 106:201-205.
36. Sin SY, Ghosh A, Tang LC, Chan V. Ten years' experience of antenatal mean corpuscular volume screening and prenatal diagnosis for thalassaemias in Hong Kong. J Obstet Gynaecol Res 2000; 26:203-208.
37. Rund D, Filon D, Strauss N, et al. Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations. Blood 1992; 79:238-243.
38. Ma ES, Chan AY, Ha SY, et al. Thalassemia screening based on red cell indices in the Chinese. Haematologica 2001; 86:1310-1311.
39. Kattamis C, Lagos P, Metaxotou-Mavromati A, Matsaniotis N. Serum iron and unsaturated iron-binding capacity in the -thalassaemia trait: their relation to the levels of haemoglobins A, A 2, and F. J Med Genet 1972; 9:154-159.
40. Lam YH, Ghosh A, Tang MH, Chan V. The risk of alpha-thalassaemia in offspring of beta-thalassaemia carriers in Hong Kong. Prenat Diagn 1997; 17:733-736.
41. Lam YH, Ghosh A, Tang MH, et al. Second-trimester hydrops fetalis in pregnancies affected by homozygous alpha-thalassaemia-1. Prenat Diagn 1997; 17:267-269.
42. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62:768-775.
43. Nasis O, Thompson S, Hong T, et al. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin Chem 2004; 50:694-701.